T cell therapy, which uses a patient's own immune cells to fight cancer, has emerged as a powerful way to treat lymphoma and ...

As the many challenges facing cell therapies are being addressed, the CAR T field continues to evolve beyond its original ...

Researchers at MIT and Harvard have developed CAR-NK cells, which could lead to more effective cancer treatment.

CAR T-cell therapy has the potential to revolutionise how we treat certain types of cancer by genetically engineering someone’s own immune cells to attack the disease – but it is also cumbersome and ...

One of the newest weapons that scientists have developed against cancer is a type of engineered immune cell known as CAR-NK ...

In vivo CAR T-cell therapies could improve access by eliminating complex logistics and reducing costs, making them more accessible to underserved populations. Traditional CAR T-cell therapies face ...

Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, or CAR-T cell therapy. Over time, the engineered immune ...

A new generation of CAR T cell therapy is bringing hope in the fight against cancer, targeting not only blood cancers but also solid tumors such as ovarian and breast cancer. Fraunhofer researchers ...

Read full article: Early voting begins in Central Florida special elections after sample-ballot debacle Read full article: 140 in a 70: ‘Super speeder’ arrested in Orlando told deputy he was late for ...

Next-generation CAR T-cell therapies aim to improve accessibility, durability, and effectiveness, addressing current ...

CAR T-cell therapy shows promise for SCLC, but significant barriers, such as tumor heterogeneity and immunosuppression, must be addressed. Early research has identified several antigens that could ...

Enabling patients to generate CAR T-cells internally could cut kidney cancer therapy costs, explained Dr. Wayne Marasco of Dana-Farber Cancer Institute. In vivo CAR T-cell therapy could drastically ...